HFE genotype and transferrin saturation in the United States

Genetics in Medicine

Volumn 5, Issue 4, 2003, Pages 304-310

  Cogswell, Mary E ^a   Gallagher, Margaret L ^b   Steinberg, Karen K ^b   Caudill, Samuel P ^b   Looker, Anne C ^c   Bowman, Barbara A ^a   Gunter, Elaine W ^b   Franks, Adele L ^d   Satten, Glen A ^b   Khoury, Muin J ^b   Grummer Strawn, Laurence M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hemochromatosis; HFE genotype; Mexican Americans; Non Hispanic blacks; Transferrin saturation

Indexed keywords

TRANSFERRIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PREVALENCE; SCHOOL CHILD; SEX; UNITED STATES;

ADOLESCENT; ADULT; CHILD; FEMALE; GENOTYPE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; TRANSFERRIN; UNITED STATES;

EID: 10744222178     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000076976.08421.AB     Document Type: Article

References (47)

1. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice Guideline Development Task Force of the College of American Pathologists, Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
2. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
3. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-1262.
4. Finch SC, Finch CA. Idiopathic hemochromatosis: An iron storage disease. Medicine Baltimore 1955;34:381-430.
5. Bomford A, Williams R. Long term results of venesection therapy in idiopathic hemochromatosis. QJ Med 1976;45:611-623.
6. Cogswell ME, McDonnell S, Khoury MJ, Franks A, Burke W, Brittenham G. Iron overload, public health, and genetics; Evaluating the evidence for hemochromatosis screening. Ann Internal Med 1998;129:971-979.
7. Barton JC, Cheatwood SM, Key TJ, Acton R. Hemochromatosis detection in a health screening program at an Alabama forest products mill. J Occup Environ Med 2002;44:745-751.
8. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1021.
9. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 1976;17:332-334.
10. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
11. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: A HuGE Review. Am J Epidemiol 2001;154:193-206.
12. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-2222.
13. Koziol JA, Felitti V, Beutler E. The effect of HFE genotypes on measurements of iron overload. Ann Intern Med 2002;137:700-701.
14. Burt MJ, George PM, Upton JD, et al. The significance of the haemochromatosis gene mutations in the general population: Implications for screening. Gut 1998;43:830-836.
15. Distante S, Berg JP, Lande K, Haug E, Bell H. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999;34:529-534.
16. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999;107:31-37.
17. Merryweather-Clarke AT, Worwood M, Parkinson L, et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 1998;101:369-373.
18. Mura C, Le Gac G, Raguenes O, Mercier AY, Le Guen A, Ferec C. Relation between HFE mutations and mild iron overload expression. Mol Genet Metab 2000;69:295-301.
19. Olynyk JK, Cullen DJ, Aquilia S, Ross E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-724.
20. Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 2001;47:202-208.
21. Rossi E, Olynyk JK, Cullen DJ, Papadopoulos G, Bulsara M, Summerville L et al. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Clin Chem 2000;46:162-166.
22. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency? Clin Chem 1998;44:2429-2432.
23. Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000;31:1160-1164.
24. Phatak PD, Ryan DH, Cappucio J, Oakes D, Braggins C, Provenzano K, et al. Prevalence and penatrance of HFE mutations in 4865 unselected primary care patients. Blood Cells, Molecules, and Diseases 2002;29:41-47.
25. Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload disease: A pooled analysis. Genet Med 2000;2:271-277.
26. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Program and collection procedures. Vital Health Stat 1994;1:1-407.
27. National Center for Health Statistics, Centers for Disease Control, and Prevention. Plan, and Operation of the Third National Health, and Nutrition Examination Survey, (NHANES III,-1994): Reference Manuals and Reports [book on CD-ROM]. Weighting and estimation methodology report. Hyattsville, Md: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1996, 1988.
28. Clayton EW, Steinberg KK, Khoury MJ et al. Informed consent for genetic research on stored tissue samples. JAMA 1995;74:1786-1792.
29. Gunter E, Lewis B, Koncikowski S. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Hyattsvile, Md: Centers for Disease Control and Prevention, 1996.
30. Livak K, Flood SJA, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Meth Appl 1995;4:357-362.
31. Perkin-Elmer. TaqMan Probe Design, Synthesis, and Purification. Foster City: Applied Biosystems Division, 1995.
32. Livak K, Marmaro J, Todd J. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995;9:341-342.
33. Lynas C. A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for detection of the HLA-H gene mutations occurring in hereditary hemochromatosis. Blood 1997;90:4235-4236.
34. Gibson RS. Principles of Nutritional Assessment. New York: Oxford University Press, 1990:362.
35. Schlesselman JJ. Case-Control Studies, Design, Conduct, Analysis. New York: Oxford University Press, 1982:254-267.
36. Botto LD, Khoury MJ. Commentary: Facing the challenge of gene-environment interaction: The two-by-four table and beyond. Am J Epidemiol 2001;153:1016-1020.
37. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press, 1989:106-108.
38. Ashford JR. Quantal response analysis. In Encyclopedia of Statistical Sciences. Kotz S, Johnson NL, Read CB, editors. New York: Wiley-Interscience, 1986.
39. SAS, Version 8.1. Copyright 1999-2000, Cary: SAS Institute, Inc.
40. Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: Accounting for the sampling design. Am J Public Health 1991;81:1166-1173.
41. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1691.
42. Brown LD, Cal TT, DasGupta A. Interval estimation for a binomial proportion. Statistical Science 2001;16:101-133.
43. National Center for Health Statistics. Analytic and Reporting Guidelines: The Third National Health and Nutritional Examination Survey, NHANES III (1988-94). Hyattsville, Md: National Center for Health Statistics, October 1996.
44. Deugnier Y, Jouanolle A-M, Chaperon J, Moirand R, Pithois C, Meyer J-F et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: A study of 9396 French people. British J Haematol 2002;118:1170-1179.
45. Barton JC, McDonnell SM, Adams PC et al. and the Hemochromatosis Management Working Group. Management of Hemochromatosis. Ann Intern Med 1998;129:932-939.
46. McClaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N et al. Hemochromatosis and the Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
47. Ashford JR. Quantal response analysis. In: Encyclopedia of Statistical Sciences. Kotz S, Johnson NL, Read CB, editors. New York: Wiley-Interscience, 1986.